Table 2 Multivariate analyses of prognostic factors for overall survival in the FUSCC
Variables | Cox proportional hazards | ||
|---|---|---|---|
Hazard ratio | 95% CI | p value | |
Adjuvant chemotherapy | 0.678 | ||
No | 1 (reference) | ||
Yes | 0. 739 | 0.176–3.093 | |
Gender | 0.019 | ||
Female | 1 (reference) | ||
Male | 0.081 | 0.010–0.658 | |
Age | 1.058 | 0.985–1.135 | 0.12 |
Clinical T stage | 0.926 | ||
T2 | 1 (reference) | ||
T3/4 | 0. 937 | 0.234–3.747 | |
Clinical N sage | 0.697 | ||
N0 | 1 (reference) | ||
N1–2 | 0.753 | 0.180–3.150 | |
CRM | 0.122 | ||
Negative | 1 (reference) | ||
Positive | 3.539 | 0.714–17.539 | |
EMVI | 0.281 | ||
Negative | 1 (reference) | ||
Positive | 0.316 | 0.039–2.568 | |
Operation | 0.361 | ||
AR | 1 (reference) | ||
APR | 1.949 | 0.466–8.159 | |
Lymph node examined | 0.064 | ||
≤ 12 | 1 (reference) | ||
> 12 | 0.854 | 0.722–1.009 | |